SC10914 Monotherapy for the mCRPC With g/s BRCA Mutation
Condition(s):Metastatic Castration Resistant Prostate CancerLast Updated:July 27, 2020Unknown status
Hide Studies Not Open or Pending
Condition(s):Metastatic Castration Resistant Prostate CancerLast Updated:July 27, 2020Unknown status
Condition(s):Metastatic Castration-resistant Prostate Cancer (mCRPC)Last Updated:March 13, 2024Recruiting
Condition(s):Prostate CancerLast Updated:March 15, 2024Recruiting
Condition(s):Metastatic Castration-Resistant Prostate Cancer (mCRPC)Last Updated:March 22, 2024Active, not recruiting
Condition(s):Prostate Cancer MetastaticLast Updated:November 13, 2023Active, not recruiting
Condition(s):Castration-Resistant Prostatic CancerLast Updated:February 26, 2024Available
Condition(s):mCRPC (Metastatic Castration-resistant Prostate Cancer); Genital Diseases, Male; Urogenital Diseases, Male; Prostatic Disease; Prostatic Neoplasms, Castration-Resistant; Prostate CancerLast Updated:January 5, 2024Not yet recruiting
Condition(s):Hormone-refractory Prostate CancerLast Updated:January 12, 2024Recruiting
Condition(s):Prostatic NeoplasmsLast Updated:December 20, 2023Active, not recruiting
Condition(s):Prostate Cancer Metastatic; Castration-resistant Prostate CancerLast Updated:January 3, 2024Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.